Clinical implication of prognostic and predictive biomarkers for castration-resistant prostate cancer: a systematic review

BACKGROUND: Diagnosis of metastatic castrate resistant prostate cancer (mCRPC) with current biomarkers is difficult and often results in unnecessary invasive procedures as well as over-diagnosis and over-treatment. There are a number of prognostic biomarkers for CRPC, but there are no validated pred...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Shengri, Lei, Zhen, Gong, Zuo, Sun, Zhonghai, Xu, Dongyuan, Piao, Minhu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7448351/
https://www.ncbi.nlm.nih.gov/pubmed/32863768
http://dx.doi.org/10.1186/s12935-020-01508-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7448351/
https://www.ncbi.nlm.nih.gov/pubmed/32863768
http://dx.doi.org/10.1186/s12935-020-01508-0

Ejemplares similares